TAKATSUGU KAJIYAMA
Assisstant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Takatsugu Kajiyama is an Assistant Professor at Chiba University Graduate School of Medicine, Japan. His research focuses on cardiovascular electrophysiology, particularly in the areas of atrial fibrillation, hypertrophic cardiomyopathy, and device interactions. He has contributed to various studies including predictors for atrioventricular nodal ablation and the efficacy of cryoablation techniques in managing arrhythmias.
Articles (12)
Background Right ventricular (RV) dysfunction is independently predictive of sudden cardiac death. This study aimed to compare the performance of different risk stratification methods for death and appropriate implantable cardioverter‐defibrillator (ICD) therapy using echocardiography and cardiac magnetic resonance imaging (CMR) to quantify RV function. Methods Consecutive patients undergoing ICD implantations who had completed both preprocedural echocardiography and CMR were retrospectively enrolled. Patients with channelopathies or arrhythmogenic right ventricular disease were excluded. The RV fractional area change (RVFAC) and estimated pulmonary artery pressure (EPAP) were calculated from echocardiography. The contraction pressure index (CPI) was defined as the quotient of the RVFAC divided by the EPAP. Both metrics were used to predict the composite endpoint of death and an appropriate ICD therapy. RV dysfunction was defined by either RVFAC < 35% or RV ejection fraction (RVEF) < 45%. Results In total, 88 patients (60.4 ± 14.7 years, 61 males) including 15 with ischemic cardiomyopathy were retrospectively enrolled. Forty‐two patients received ICDs as secondary prevention. The mean RVFAC, CPI, and RVEF were 35.9% ± 9.22%, 1.4% ± 0.7%/mmHg, and 39.5% ± 14.4%, respectively. Regarding the composite endpoint, the best cut‐off value of the CPI was 1.59 (specificity 0.45, sensitivity 0.96, ROC‐AUC 0.68). The hazard ratio of a low RVFAC was 3.28 (95% CI: 1.39–7.77, p = 0.007, concordance = 0.622), a low CPI, 14.2 (95% CI: 1.91–104.9, p = 0.010, c = 0.665), and a low RVEF, 3.44 (95% CI: 1.17–10.1, p = 0.003, c = 0.620). Conclusion Both CMR‐derived RVEF and the echocardiographic CPI predicted appropriate ICD therapy and death. The CPI may provide superior risk stratification.
Year:
2026
Year:
2024
Year:
2023
Year:
2022
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (1)
masahiro nakano
Chiba University Graduate School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.